Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC Committee Proposes New Nanomaterials Risk Assessment Procedure

This article was originally published in The Tan Sheet

Executive Summary

The European Commission Health and Consumer Protection Directorate is seeking comments on the current approach to risk assessment of nanomaterials and the best methods and practices to determine the potential risks they pose

You may also be interested in...



EPA Would Regulate Nano Materials Under Research Project’s Proposal

A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight

EPA Would Regulate Nano Materials Under Research Project’s Proposal

A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight

EPA Would Regulate Nano Materials Under Research Project’s Proposal

A report commissioned by the Project on Emerging Nanotechnologies proposes a five-year strategy lawmakers and the Environmental Protection Agency, among others, can follow to create an "intelligent" approach to nanotechnology oversight

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel